Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease.

ABSTRACT:

Aims

To quantify patterns of conventional and newer antidiabetic medication use in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD).

Methods

We used data from a large claims and integrated dataset that includes employed and commercially insured patients in the US to select patients who had T2DM and CKD with information on laboratory values and prescriptions for antidiabetic medications from January 1, 2014 to January 1, 2015. We stratified the analyses by sociodemographic variables.

Results

In a cohort of 38,577 patients with T2DM and CKD, we found wide variation in the treatment of T2DM by CKD stage as well as by several sociodemographic factors. Although metformin was the most commonly prescribed medication, only about half of patients

SUBMITTER: Rhee JJ 

PROVIDER: S-EPMC6823164 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature